LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
01 1LGM Pharma
02 1Moehs Iberica
03 1Olpha
04 1Alembic Pharmaceuticals Limited
05 1Amsa Spa
06 1Biotechnica DWC
07 1Cilag AG
08 1Clarochem Ireland
09 1Dr. Raju’s Pharma Solutions
10 1Freemen Nutra
11 1Hangzhou Longshine Bio-Tech
12 1Hongrui Fine Chemical
13 1Magle Chemoswed
14 1Northeast Pharmaceutical Group Co Ltd
15 1Tecoland Corporation
16 1Tianjin Minxiang Pharmaceutical Chemical
17 1Zhejiang Apeloa Kangyu Pharmaceutical Co. Ltd
18 1Blank
01 1Algeria
02 6China
03 1India
04 1Ireland
05 1Italy
06 1Latvia
07 1Spain
08 1Sweden
09 1Switzerland
10 3U.S.A
11 1Blank
01 4Active
02 3Inactive
03 11Blank
01 2Valid
02 16Blank
01 1223MF10070
02 17Blank
01 18Blank
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-16
Pay. Date : 2014-05-13
DMF Number : 6924
Submission : 1987-04-08
Status : Active
Type : II
Certificate Number : R1-CEP 2000-014 - Rev 08
Issue Date : 2023-05-25
Type : Chemical
Substance Number : 463
Status : Valid
NDC Package Code : 52932-0707
Start Marketing Date : 2009-09-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Ca